These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cliical aspects of lymphogranulomatosis maligna. Voutilainen A; Kalima TV Ann Med Intern Fenn; 1967; 56(3):99-103. PubMed ID: 4169672 [No Abstract] [Full Text] [Related]
4. [Medical and social factors in the work capacity expertise of lymphogranulomatosis patients]. Anikin BS Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):50-4. PubMed ID: 7301790 [No Abstract] [Full Text] [Related]
5. [Use of vinblastine in the late stages of lymphogranulomatosis]. Anikin BS; Nesterovich NA Klin Med (Mosk); 1974 Oct; 52(10):105-9. PubMed ID: 4437057 [No Abstract] [Full Text] [Related]
6. [Causes for failures in the treatment of localized forms of lymphogranulomatosis]. Pakulina LE; Chekharina EA Vopr Onkol; 1973 May; 19(5):36-41. PubMed ID: 4714734 [No Abstract] [Full Text] [Related]
7. [On prognostic factors in the treatment of lymphogranulomatosis]. Ignat'eva IA Vopr Onkol; 1966; 12(6):35-9. PubMed ID: 6000103 [No Abstract] [Full Text] [Related]
8. [Late results of treating specific liver involvement in lymphogranulomatosis]. Demina EA Ter Arkh; 1986; 58(9):55-7. PubMed ID: 3787492 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of malignant lymphoma]. Stojimirović E; Jokanović R; Vuković I; Kojić V; Bubnjevacki G Srp Arh Celok Lek; 1973 May; 101(5):329-37. PubMed ID: 4595466 [No Abstract] [Full Text] [Related]
12. [Clinical findings in lymphogranulomatosis]. Weinreich J; Sander DU Med Monatsschr; 1970 Feb; 24(2):54-8. PubMed ID: 5436970 [No Abstract] [Full Text] [Related]
13. [Incidence and diagnosis of recurrence in lymphogranulomatosis with mediastinal involvement]. Keller H; Hering K Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:136-8. PubMed ID: 4366587 [No Abstract] [Full Text] [Related]
14. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease]. Aghai E; Kende G; Many A; Ramot B Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045 [No Abstract] [Full Text] [Related]
15. [Social and occupational rehabilitation of lymphogranulomatosis patients in late periods after radiation therapy]. Baĭsogolov GD; Shishkin IP Med Radiol (Mosk); 1983 Nov; 28(11):29-35. PubMed ID: 6645826 [TBL] [Abstract][Full Text] [Related]
16. [Characteristics of the clinical manifestations of lymphogranulomatosis in children and adults]. Kolygin BA; Chekharina EA Vopr Onkol; 1981; 27(1):23-6. PubMed ID: 7006213 [TBL] [Abstract][Full Text] [Related]
17. [N-nitrosomethylurea in the chemotherapy of lymphogranulomatosis]. Vermel' AE; Korman NP; Magagina GE; Raevskiĭ IG Vopr Onkol; 1974; 20(3):8-13. PubMed ID: 4439805 [No Abstract] [Full Text] [Related]
18. [Hodgkin's disease (study of 99 cases occurring during a 10-year period)]. Delage JM; Barry A; Petitclerc C; Villeneuve B; Jobin F; Lehner-Netsch G; Lyonnais J; Leblond PF Union Med Can; 1978 Oct; 107(10):920-6. PubMed ID: 705954 [No Abstract] [Full Text] [Related]
19. [Radiation therapy of lymphogranulomatosis: Results under special consideration of recurrences in the early stages (author's transl)]. Voss AC; Baier N Strahlentherapie; 1980 Feb; 156(2):105-10. PubMed ID: 7355409 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effect of natulan in generalized forms of lymphogranulomatosis]. Vinokurova NA; Gershanovich ML Vopr Onkol; 1974; 20(8):7-13. PubMed ID: 4428646 [No Abstract] [Full Text] [Related] [Next] [New Search]